Fahr's disease

Fahr's Disease, also known as Fahr's Syndrome or Idiopathic Basal Ganglia Calcification (IBGC), is a rare, neurodegenerative disorder characterized by abnormal deposits of calcium in areas of the brain that control movement, including the basal ganglia and the cerebral cortex. This condition is not uniformly defined, leading to confusion and inconsistency in its classification and diagnosis. Fahr's Disease is typically sporadic, but familial cases have been reported, suggesting a genetic component in some instances.

Symptoms

The symptoms of Fahr's Disease can vary widely among individuals but generally include a combination of neurological and psychiatric manifestations. Common neurological symptoms include:

• Dystonia - involuntary muscle contractions that cause repetitive or twisting movements.
• Parkinsonism - a group of movement abnormalities that resemble Parkinson's disease, such as tremors, slow movement (bradykinesia), and stiffness.
• Chorea - sudden, involuntary, jerky movements.
• Ataxia - lack of muscle coordination affecting speech, eye movements, the ability to swallow, walking, and picking up objects.

Psychiatric symptoms may include:

• Cognitive impairment
• Mood swings
• Psychosis
• Dementia

Causes

The exact cause of Fahr's Disease remains unknown. However, it is believed to involve a combination of genetic and environmental factors. Familial cases of Fahr's Disease have been linked to mutations in several genes, including SLC20A2, PDGFRB, PDGFB, and XPR1, which are involved in the regulation of calcium and phosphate metabolism in the brain.

Diagnosis

Diagnosis of Fahr's Disease is primarily based on the presence of characteristic symptoms, a detailed patient history, and the exclusion of other conditions that could cause similar symptoms. Key diagnostic tools include:

• Neuroimaging techniques, such as Computed Tomography (CT) scans or Magnetic Resonance Imaging (MRI), which can reveal calcifications in the basal ganglia and other brain regions.
• Genetic testing to identify mutations associated with familial cases of the disease.

Treatment

There is no cure for Fahr's Disease, and treatment focuses on managing symptoms and improving quality of life. Treatment options may include:

• Medications to manage movement disorders, such as antipsychotics for chorea or dopamine replacement therapy for parkinsonism.
• Physical therapy to help with mobility and prevent complications from muscle stiffness and weakness.
• Psychiatric and cognitive therapies to address mental health issues and cognitive decline.

Prognosis

The prognosis for individuals with Fahr's Disease varies widely depending on the severity of symptoms and the onset of the disease. While the condition is progressive, the rate of progression can differ significantly among patients. Early diagnosis and management of symptoms can help improve the quality of life.

Epidemiology

Fahr's Disease is considered rare, but the exact prevalence is unknown due to diagnostic challenges and the potential for misdiagnosis. Both men and women are affected, and symptoms typically appear in adulthood, although cases in children have been reported.

See Also

• Neurodegenerative diseases
• Basal ganglia
• Calcification

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian